Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development

Innovative therapies to complement current treatments are needed to curb the growing incidence of fatal overdoses related to synthetic opioids. Murine and chimeric monoclonal antibodies (mAb) specific for fentanyl and its analogs have demonstrated pre-clinical efficacy in preventing and reversing dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hicks, Dustin, Baehr, Carly, Silva-Ortiz, Pedro, Khaimraj, Aaron, Luengas, Diego, Hamid, Fatima A., Pravetoni, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746415/
https://www.ncbi.nlm.nih.gov/pubmed/36194773
http://dx.doi.org/10.1080/21645515.2022.2122507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746415/
https://www.ncbi.nlm.nih.gov/pubmed/36194773
http://dx.doi.org/10.1080/21645515.2022.2122507

Ejemplares similares